Revvity to acquire ACD/Labs.

Revvity, company that specializes in life sciences and diagnostics, agreed to acquire ACD/Labs, a provider of scientific software. Financial terms were not disclosed. This acquisition expands the breadth and depth of Revvity Signals’ solutions for bridging the gap between analytical data and actionable insights, further strengthening its ability to accelerate scientific innovation.